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Novel strategies in diabetes therapy would obviously
benefit from the use of beta (b) cell stem/progenitor
cells. However, whether or not adult b cell progeni-
tors exist is one of the most controversial issues in
today’s diabetes research. Guided by the expression
of Neurogenin 3 (Ngn3), the earliest islet cell-specific
transcription factor in embryonic development, we
show that b cell progenitors can be activated in
injured adult mouse pancreas and are located in
the ductal lining. Differentiation of the adult progeni-
tors is Ngn3 dependent and gives rise to all islet
cell types, including glucose responsive b cells that
subsequently proliferate, both in situ and when cul-
tured in embryonic pancreas explants. Multipotent
progenitor cells thus exist in the pancreas of adult
mice and can be activated cell autonomously to in-
crease the functional b cell mass by differentiation
and proliferation rather than by self-duplication of
pre-existing b cells only.INTRODUCTION
Numerous mechanisms that control differentiation of endocrine
progenitor cells in the embryonic pancreas have been disclosed
(Jensen, 2004) but our knowledge on the existence of precursors
and generation of islet cells in the postnatal pancreas depends
merely on descriptive data and indirect proof (Bonner-Weir and
Weir, 2005; Bouwens and Rooman, 2005). Long-term culture
of heterogeneous populations of pancreas cells favors enrich-
ment of beta (b) cell-like phenotypes (Bonner-Weir et al., 2000;
Seaberg et al., 2004; Suzuki et al., 2004) that under certain con-
ditions were able to reverse hyperglycemia when transplanted in
diabetic mice (Hao et al., 2006; Ramiya et al., 2000). None of
these studies, however, was conclusive in demonstrating theexistence and origin of a bona fide b cell progenitor in postnatal
pancreas. The elusiveness of this cell type reached a summit
when genetic lineage tracing provided evidence that pre-existing
b cells, rather than stem/progenitor cells, are the major source of
new b cells in adult mice both under normal physiological condi-
tions and after 70% or 50% pancreatectomy (Dor et al., 2004;
Teta et al., 2007).
Two major problems are at the basis of this ambiguous sce-
nario: the slow turnover of adult b cells and the lack of specific
markers to trace their origin. We overcame these hurdles by (1)
forcing the generation of new b cells through partial duct ligation
(PDL) in the pancreas of adult mice and (2) using transgenic re-
porter mice that allow tracing of the promoter activity of Ngn3
as a marker of adult progenitor cell recruitment. PDL stimulates
doubling of the b cell mass in rats (Wang et al., 1995), andNgn3 is
an essential master switch for differentiation of embryonic islet
cell progenitors (Apelqvist et al., 1999; Gradwohl et al., 2000;
Gu et al., 2002; Schwitzgebel et al., 2000) and extremely rare
in normal postnatal pancreas (Gu et al., 2002).
RESULTS
Activation of Ngn3 Gene Expression Induces b Cell
Hyperplasia in Adult Mice
Pancreatic b cells have a slow turnover under normal physiolog-
ical conditions but expand rapidly under certain experimental
conditions like PDL (Wang et al., 1995). In Balb/c mice, the
duct leading to the pancreatic tail was closed while the organ’s
head located adjacent to the stomach and duodenum remained
unaffected. Within 1 week far most of the acinar exocrine cells
underwent apoptosis (Figure S1A) and likely were scavenged
by CD45+ cells recruited to the ligated tail part of pancreas
(Figure S1C) (Scoggins et al., 2000). Moreover, duct cell-cycle
activity was strongly elevated (Figures S1B and S2E), and conse-
quently, the density of duct structures significantly increased
(Figures 1A, S1A, and S1B). The weight of the pancreatic tail de-
creased (Figure S2A), while body weight and glycemia remained
unaffected (Figures S2B and S2C). The total insulin+ cell mass inCell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc. 197
Figure 1. PDL Activates Ngn3 Gene Expression and
Increases b Cell Mass in Adult Pancreas
(A–C) In 8-week-old BALB/C mice, the duct that connects pancre-
atic tail and duodenum was ligated, and the ligated tail of PDL pan-
creas at day 7 (PDL D7) was compared to the tail of sham-treated
pancreas (CTR) by immunohistochemistry for cytokeratin+ (CK)
ductular complexes and insulin+ cells (A). Magnification bars are
100 mm. Several parameters weremeasured (see Experimental Pro-
cedures) at 3, 7, 14, and 30 days following ligation. PDL increased
the insulin+ cell mass (mg) (B) and the insulin content (mg) (C) of
the tail part of pancreas more than 2-fold (black bars) as compared
to the unligated head of the same pancreas (gray bars) and the tail of
a sham-operated pancreas (white bars).
(D) At 3, 7, 14, and 30 days after PDL and 1 hr before sacrifice, the
nucleotide analog BrdU (50 mg/kg) was injected intraperitoneum.
The number of insulin+ BrdU+ cells on pancreatic tissue sections
was 10-fold higher in the ligated tail versus control tail or head of
pancreas. A similar relative increase of BrdU+ b cells was seen
when BrdU had been applied 16 hr before sacrifice (4.60% ±
0.51% in ligated tail of pancreas at day 7 following PDL versus
0.66% ± 0.15% in unligated tail).
(E) A more than 50-fold increase of Ngn3 transcripts was observed
in ligated versus unligated part of pancreas by real time RT-PCR
using a mouse Ngn3-specific TaqMan probe. All results shown
are representative of three or more independent experiments.
*: p < 0.001 ligated versus unligated pancreas tail.198 Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc.
the ligated part of pancreas increased more than 2-fold within 1
week following surgery (Figures 1B and S1D), and the absolute
amount of immunoreactive insulin had doubled 1 week later,
a lag period likely needed for b cell maturation (Figure 1C). The
individual b cell size remained similar under all conditions tested
(Figure S2D), meaning that the treatment induced an increase
in cell number rather than in cell size. During this period, the num-
ber of b cells in active cell cycle increased 10-fold as established
by incorporation of the nucleotide analog BrdU (Figures 1D and
S1E). As PDL robustly induced generation of new b cells, we in-
vestigated the importance of progenitor cell activation and b cell
proliferation in doubling of the b cell mass. A strong activation of
expression of Ngn3, a well-established marker for embryonic is-
let cell progenitors, was observed specifically in the ligated part
of adult mouse pancreas within 3 days following injury. Maximal
levels of Ngn3 transcript were reached within 1 week and subse-
quently decreased slowly (Figure 1E). Besides neo-formation of
b cells, the number of apoptotic b cells increased significantly
(Figure S1F). Apoptotic b cells were not preferentially in active
cell cycle (Figure S1G).
To investigate the causal relationship between the doubling
of b cell mass and the activation of Ngn3 gene expression, the
latter was knocked down during PDL-induced formation of
endocrine pancreas. Recombinant lentiviruses that encode 2
Ngn3-specific short hairpin (sh) interfering RNA molecules (Le-
sh1Ngn3 and Le-sh2Ngn3), or a control, scrambled sequence
(Le-scr) (Baeyens et al., 2006) were injected into the pancreatic
duct via the papilla Vateri, followed by ligation of the tail duct.
The viruses constitutively express the reporter protein eGFP
that allowed us to evaluate the efficiency and specificity of infec-
tion in the whole organ and in tissue sections. Injection of re-
porter virus in sham-treated pancreas transduced 62% of total
cells (Figure S3). When virus injection was combined with duct
ligation, 18% ± 10% of total cells expressed detectable levels
of eGFP 1 week after surgery (Figure 2A). Following infection
with lentivirus expressing shRNA, acinar cells disappeared sim-
ilarly as in control PDL pancreas, and no off-target effects on
differentiation and proliferation of duct cells were observed (Fig-
ures S4A–S4C). In Le-shNgn3-injected pancreas the Ngn3 tran-
script abundance was 70% ± 11% (sh1) and 49% ± 4% (sh2)
lower than in sham- and Le-scr-injected PDL pancreas at day
7 (Figures 2B, upper and S5). PDL-induced increase of the
b cell mass was prevented by 66% ± 17% (sh1) and 26% ±
10% (sh2) following infection with Le-shNgn3 (Figure 2B, mid-
dle). These data strongly suggest that b cell formation following
PDL depends at least partly on Ngn3 activity. The induced BrdU
labeling index of insulin+ cells decreased with 77% ± 10%
(sh1) and 32% ± 12% (sh2) by Le-shNgn3 versus Le-scr injection
(Figure 2B, lower), indicating that an important fraction of BrdU+
b cells (Figure 1D) were derived from differentiated Ngn3+ cells.
Ngn3+ Cells in Adult Pancreas Originate from Hormone
Progenitors Near Ducts and Become Islet Cells
Given the activatedNgn3 expression in injured pancreas of adult
mouse, we attempted to track these islet progenitor cells in
transgenic Ngn3-nLacZ mice, expressing a nuclear b-galactosi-
dase (b-gal) reporter protein under control of a 6.9 kb genomic
sequence that includes theNgn3 promoter and faithfully recapit-ulates the spatial expression ofNgn3 in the embryonic as well as
in the adult pancreas (G.M. and G.G., unpublished data). Histo-
chemistry for b-gal activity revealed blue nuclei in adult mouse
duodenum (data not shown), known to constitutively express
Ngn3 in enteroendocrine progenitor cells (Jenny et al., 2002;
Schonhoff et al., 2004). The Ngn3 reporter was also detected
in the ligated tail of PDL pancreas but not in the unligated head
or in the pancreatic tail of sham-operated mice. The localization
of 785 b-gal+ cells was examined in six mice, 7 days following
PDL (Figure 3A). Of all b-gal+ cells 15% ± 1%were immunoreac-
tive for duct cell-specific cytokeratins (CK) (Figure 3B) and half of
the b-gal+CK+ cells were lining the duct lumen as shown by con-
focal scanning microscopy (Figure 3C). Furthermore, Ngn3 was
expressed in duct-lining cells that activated Pdx1 expression fol-
lowing PDL (Figure 3I). No marker typical for any pancreatic cell
type was expressed on 51% ± 2% b-gal+ cells (Figure 3D), one-
third of which were still in contact with CK+ duct cells (Figure 3B).
Immunohistochemical staining with a Ngn3-specific antibody
showed that the Ngn3+ cells in duct-ligated pancreas were de-
void of islet cell-specific hormones (Figures 3E–3F). On the other
hand, the long half-life of the reporter protein b-gal (Gonda et al.,
1989) allowed tracing the fate of Ngn3+ cells to their endocrine
descendants. Indeed, 34% ± 4% of b-gal+ cells contained tran-
scripts encoding islet hormones at day 7 following PDL (Figures
3G and 3H). Half the number of hormone-expressing bGal+ cells
was still in contact with duct cells but none of these were part
of the luminal lining. No b-gal+ cells costained for amylase (not
shown). While these lineage-tracing data strongly suggest that
the observed Ngn3+ cells originate from islet hormone cells
among the lining of ducts andmigrate to become hormone+ cells
within the islet structures in adult mice, they do not fully exclude
the alternative possibility that endocrine cells dedifferentiated
to Ngn3+ cells. Therefore, we traced permanently labeled b cells
from INS-Cre/R26R mice with PDL and found the label absent
from Ngn3+ cells (Figure S6B) supporting differentiation of
Ngn3+-to-islet cells.
Ngn3+ Progenitor Cells Can Be Purified from Adult
Mouse Pancreas
Based on the number of b-gal+ cells in 30 tissue sections from
the PDL pancreas of three mice, approximately 5000 b-gal+ cells
were present in the ligated tail, a sufficiently high number to
endeavor their isolation. By flow cytometry, Ngn3+ cells were
isolated from the PDL pancreas of reporter mice that express
eGFP under control of the same 6.9 kb Ngn3 promoter fragment
as used in the Ngn3-nlacZmice. As for b-gal, the half-life of eGFP
(Corish and Tyler-Smith, 1999) exceeds that of Ngn3 (Lee et al.,
2001), and consequently the reporter protein was still present
in a fraction of the hormone-positive descendants of the preen-
docrine cells (data not shown). These GFP+ cells with hormone-
containing vesicles were excluded, and only nongranulated
GFP+ cells were considered as endocrine progenitors. Seven
days following partial duct ligation, PI/GFP+/TSQ/LowSSC
cells (termed GFP/LSSC cells from hereon) that were viable,
green fluorescent, and contained only few granules could be
isolated from PDL pancreas of Ngn3-eGFP mice (Figure 4A).
The transcript encoding Ngn3 was 200-fold enriched, and those
encoding insulin and glucagon were very rare in the progenitorCell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc. 199
Figure 2. Knockdown of Ngn3 Impairs PDL-Induced b Cell
Generation
(A) The pancreatic duct of adult BALB/Cmice was injected with recombi-
nant lentiviruses encoding reporter eGFP and two different shRNAs for
specific interference with Ngn3 transcript (Baeyens et al., 2006) (Le-
sh1Ngn3-eGFP and Le-sh2Ngn3-eGFP) or control sequence (Le-scr-
eGFP), immediately followed by PDL. The efficiency of infection was de-
termined 7 days following sham- or virus injection and PDL by direct fluo-
rescence of whole pancreas tail (upper row) and by immunostaining for
the reporter on pancreas sections (middle row). The specificity was de-
fined by the fraction of GFP+ cells that immunostained positive for duct
cell-specific cytokeratins (47% ± 9%) or the islet cell marker synaptophy-
sin (5% ± 2%). As most acinar cells had disappeared at day 7 following
PDL, no GFP+ cells were amylase+ (lower rows).
(B) As a result of the Ngn3-specific knockdown by Le-shNgn3-eGFP in
day 7 PDL pancreas (black bar), the fold activation of Ngn3 was de-
creased by 70% ± 11% (sh1) and 49% ± 4% (sh2) as compared to the
effect of Le-scr-eGFP infection (gray bar, upper). The b cell mass more
than doubled in the tail of Le-scr-infected PDL pancreas compared to
sham-operated control (hatched bar), but this effect was inhibited by
66% (sh1) and 26% (sh2) following infection with Le-shNgn3 (middle).
Ngn3 knockdown also reduced the increase in the number of insulin+
cells that incorporated BrdU following Le-shNgn3 injection (lower).
Abundance of transcripts was quantified by real-time RT-PCRusing Taq-
Man probes. b cell mass and the fraction of BrdU+ insulin+ cells were de-
termined as in Figure 1, except that BrdUwas supplied 16 and 2 hr before
sacrifice. All results shown are representative of three independent ex-
periments. *: p < 0.05 Le-shNgn3-eGFP versus Le-scr-eGFP infected
PDL pancreas. Magnification bars are 100 mm.200 Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc.
population as compared to nonsorted PDL pancreas cells
(Figure 4B). A similar cell population was isolated from the pan-
creas of Ngn3eYFP/+ knock add-on mice (Mellitzer et al., 2004),
corroborating faithful recapitulation of Ngn3 expression in the
Ngn3-eGFP mice (Figure 4D) (data not shown). The GFP/LSSC
cell population represented 0.04% of the total number of sorted
pancreatic cells. Of this sorted population, 93% ± 4% immuno-
stained GFP+, 90.1% ± 5% Ngn3+, and none were insulin+
(Figure 4E). As expected, the fraction of insulin+ cells was high
in the GFP+/TSQ+/HSSC (termed GFP/HSSC from hereon) cell
population (85% ± 10%) and in total pancreas (3.0% ± 0.8%).
GFP/LSSC cells, sorted from GCG-Cre/R26R/Ngn3-eGFP
mice pancreas (Figure S6C) 7 days following PDL, lacked b-gal
(800 cells counted), while the reporter was expressed in
5% of islet cells (Figure S6D). In addition to the differentiation of
Ngn3+-to-b cells (Figure S6B) and the similar amount of
Ngn3 transcripts in islets isolated from the tail of ligated and
sham-treated pancreas (lower than in total PDL pancreas)
(Figure 4C), these data provide strong evidence against islet-
to-Ngn3+ cell dedifferentiation.
Due to the controversial aspect of progenitor cells in adult pan-
creas, we compared these GFP/LSSC cells with Ngn3+ cells iso-
lated from E13.5 embryonic pancreas and from adult duodenal
crypt region, as these Ngn3+ cell types are generally accepted
to be genuine endocrine progenitors (Gu et al., 2002; Jenny
et al., 2002; Schonhoff et al., 2004). While 99.8% of the sorted
cells from embryonic pancreas and adult duodenum were
GFP-positive, none immunostained positive for insulin. The
abundance of Ngn3 transcripts in these cells was more than
100-fold higher than in the nonsorted cell populations (data not
shown). Electron micrographs of GFP/LSSC cells isolated from
embryonic and adult PDL pancreas showed rounded cells that
were 3-fold smaller than adult mouse b cells (985 ± 112 mm3
versus 3052 ± 178 mm3) and had relatively large nuclei (695 ±
98 mm3 versus 565 ± 76 mm3) with a remarkable amount of het-
erochromatin in the periphery of the nuclei (Figure 4F). The ultra-
structural features of Ngn3+ cells isolated from adult duodenum
were similar to those of the pancreatic GFP/LSSC cells (data not
shown). In contrast to the many dark secretory granules contain-
ing mature insulin that are present in all differentiated b cells,
tected by histochemical staining of Ngn3-reporter activity (B–D, G, and H). The
identity of the b-gal-expressing cells was determined by combined immuno-
histochemical detection of ductal cytokeratins and/or islet hormones (B–D,
G, and H). An overview of the distribution of coexpressing cells was based
on the examination of 785 b-gal+ cells in the ligated pancreas of 6 mice (A).
15% ± 1% of all b-gal+ cells expressed duct cell-specific cytokeratins (CK)
but no insulin (INS) (B, arrow) or other islet cell hormones (not shown). Half
of the b-gal+ CK+ hormone cells were in direct contact with the duct lumen
(C). Half of the b-gal+ cells did not express CK or islets markers (here INS)
(D), one-third of which were in contact with CK+ cells (B, arrowhead). While
immunostaining for endogenous Ngn3 showed no coexpression with islet hor-
mones, insulin (E, E0), glucagon (GCG), somatostatin (SST), or pancreatic poly-
peptide (PP) (F), one-third of all b-gal+ cells were hormone+ indicating that
Ngn3+ cells are the source of endocrine islet cells (G and H). DAPI (blue) (E
and F) and PI (red) (C) stain the nuclei. All sampling was done 1 week following
PDL. NoNgn3 or b-gal signal was detected in tail of unligated or head of ligated
pancreas. Sham-treated and PDL D7 pancreas were stained simultaneously
for Pdx1 and Ngn3 showing coexpression in cells lining the duct of PDL
pancreas (I). Magnification bars are 10 mm.Figure 3. New Islet Cells Derive from Hormone Progenitors among
the Lining of Ducts in PDL Pancreas
(A–I) Duct ligation induced Ngn3 promoter activation in the pancreatic tail of
the outbred CD1 x C57BL/6 strain of Ngn3-nlacZ reporter mice (data not
shown), similar as in Balb/c mice. Expression of lacZ, coding for the long-living
reporter b-gal under the control of Ngn3 promoter sequences, allowed track-
ing of the Ngn3-expressing cells and their descendants. Ngn3+ cells were de-Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc. 201
Figure 4. Ngn3+ Cells Isolated from Adult
Pancreas Have an Embryonic Islet Cell
Progenitor Phenotype
(A) GFP+ cells were isolated by flow cytometry
from adult PDL pancreas (day 7) of Ngn3 reporter
mice, based on GFP expression and low degree
of granulation. First, viable Ngn3+ cells were iso-
lated based on their GFP fluorescence and capacity
to exclude propidium iodide. Then, they were sepa-
rated from the hormone+ cells according to their low
degree of cellular granulation that was evaluated in
two ways, namely by binding of the Zn2+-chelator
6-methoxy-8-p-toluene sulfonamide quinoline (TSQ)
to hormone peptides in secretory vesicles and cel-
lular sideward scattering (SSC) properties. The re-
sulting cell population is PI/GFP+/low SSC/TSQ,
in brief GFP/LSSC (red window), while granulated
GFP+ cells are PI/GFP+/high SSC/TSQ+ or GFP/
HSSC (green window). GFP/LSSC cells were not
detected in wild-type littermates.
(B–D) Quantification of transcript levels by RT-
QPCR (see Table S1 and Experimental Procedures).
RNAwas extracted from the total population of non-
sorted pancreas cells (white bars), GFP/LSSC cells
(gray bars), GFP/HSSC cells (black bars), and islets
from sham-treated (vertical lines) or PDL (horizontal
lines) pancreas from transgenic mice with random
Ngn3-eGFP insertion (B and C) or eYFP added on
the Ngn3 locus (D). All RT-PCR results shown are
representative of three independent experiments.
(E) Immunodetection of insulin+ and Ngn3+ cells on
cytospins of nonsorted and sorted cells from PDL
D7 pancreas. Enrichment of GFP+ and Ngn3+ cells
and depletion of insulin+ cells in theGFP/LSSC frac-
tion (0 insulin+ on 3000GFP/LSSC cells, a fraction of
the GFP/LSSC cells from 48 PDL mice) was con-
firmed by immunocytochemistry.
(F) Ultrathin sections of GFP/LSSC (upper panels)
and GFP/HSSC cells (lower left panel) from adult
PDL (day 7) and of GFP/LSSC cells from E13.5 pan-
creas (lower right panel) were analyzed on transmis-
sion electron micrographs. All cells were isolated
from Ngn3-eGFP transgenic mice. Magnification
bars are 100 mm in (E) and 10 mm in (F).
(G) Compared to nonsorted pancreas cells (Total
cells) or GFP/HSSC cells, the expression of progen-
itor marker Ngn3 and of developmental transcrip-
tion factors Ptf1a, Sox9, HNF6, and Nkx6.1, located
upstream of Ngn3 during embryogenesis, was high
in GFP/LSSC cells while that of its direct targets and
differentiationmarkers was low or absent. The pres-
ence of transcripts was determined by conventional
RT-PCR amplification with specific primers (Exper-
imental Procedures). cDNA from adult mouse islet
cells and from GFP+ cells isolated from E13.5 pan-
creas of Ngn3-GFP reporter mice served as control
(CTR). The negative control (-) contained no cDNA.202 Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc.
most GFP/LSSC cells from embryonic or adult pancreas were
nongranulated and few granules were found in only 5% ± 1%
of them. The latter had inclusions of low electron density, without
a halo (Figure 4F), typical for cells with unprocessed hormone
(Orci et al., 1985) and another indication of the immature cell
state. Ngn3 cells isolated from adult regenerating pancreas
thus strongly resemble progenitors of endocrine cells in embry-
onic pancreas and adult duodenum.
More extensive gene-expression profiling revealed that tran-
scription factors expressed upstream of Ngn3 in early pancreas
epithelium (Ptf1a, Sox9, HNF6, and Nkx6.1) were also enriched
in GFP/LSSC cells, while the ones that continue to be expressed
in mature islet cells (Hlxb9 and Pdx1) were higher in GFP/HSSC
than LSSC cells. Transcription factors acting downstream of
Ngn3 (IA1, Pax4, Arx, Nkx2.2, NeuroD1, Pax6) were overall low
in GFP/LSSC cells, also illustrating their early endocrine differen-
tiation status (Figure 4G).
Ngn3+ Cells from Adult Pancreas Differentiate to
Functional Islet Cells In Vitro
When cultured in 1% or 10% serum, either in suspension, as
monolayer, or in 3D collagen gel, over 90% of the GFP/LSSC
cells died after 1 day (data not shown). All factors required for en-
dogenous Ngn3+ cells to survive and differentiate into islet
cells should, however, be present in the embryonic pancreas in
situ but also in embryonic organ culture (Miralles et al., 1998)
(Figures S7A–S7C).We therefore considered the ex vivo cultured
embryonic mouse pancreas as an appropriate microenviron-
ment to investigate the capacity of the Ngn3+ cells isolated
from adult mouse pancreas to differentiate into mature islet
cells (Figure 5A). In wild-type (WT) E12.5 pancreatic explants,
the differentiating endocrine cells derived from endogenous
Ngn3-expressing cells, since no islet hormone+ cells appeared
in explants from Ngn3 homozygous null mutant embryos
(Figure 5B). To exclude interference with these endogenous
embryonic Ngn3+ cells, the isolatedGFP/LSSC cells fromnormal
embryonic and ligated adult pancreas of Ngn3-eGFP mice were
microinjected in embryonic Ngn3/ pancreas. No insulin or glu-
cagon peptide or transcript could be detected in the engrafted
Ngn3/ explants following 1 day of culture (Figure 5B,C). After
7 days of culture, WT explants as well as engrafted—but not
sham-injected—Ngn3/ explants contained transcripts encod-
ing the four islet hormones as well as their corresponding pep-
tides (Figures 5B and 5C). No cell expressed more than one hor-
mone simultaneously (data not shown). We further examined
whether the observed endocrine differentiation was cell autono-
mous or whether fusion or signaling between injected adult
Ngn3+ cells and explanted embryonic pancreas was involved.
First, when GFP/LSSC cells were preincubated with CellTracker
Orange (CMTMR) and injected in explanted pancreas of Ngn3/
embryonic mice, the injected GFP/LSSC cells differentiated
since some of them expressed insulin already at day 4 of culture
(Figure S8A). Second, when mouse GFP/LSSC cells were cul-
tured in explants of rat embryonic pancreas and differentiating
b cells were immunostained by species-specific antibodies
directed against insulin C peptide (Blume et al., 1990), both
mouse and rat cells independently differentiated to C peptide+
cells (Figure S8B). Finally, when GFP/LSSC cells isolated fromNgn3-eGFP mice that constitutively express b-gal were cultured
in pancreas explants from embryonic Ngn3/ mice, all differen-
tiated, hormone+ cells were b-gal+ (Figure S8C). Consequently,
the endocrine cells originate directly from the injected GFP/
LSSC cells without cell fusion.
When explants were labeled with BrdU during the last 16 hr of
culture, the injected GFP/LSSC cells did not enter the cell cycle
after 1 day, while 22% ± 6.2% of the newly differentiated insulin+
cells were active in S phase at day 7 (Figure 5D).
WT explants contained 137 ± 37 ng of insulin following 7 days
of culture (versus 1.2 ± 0.8 ng at day 1) and Ngn3/ explants
supplemented with adult GFP/LSSC cells had 35 ± 7 ng insulin
(versus 0.2 ± 0.2 at day 1). To evaluate the degree of differentia-
tion of the GFP/LSSC cells, we measured glucose responsive-
ness of the insulin release. Glucose induced a 1.5-fold increase
of insulin secretion from explanted E12.5 pancreas ofWTmice at
day 7 of culture (Figure 5E). Embryonic pancreas from Ngn3/
mice acquired glucose responsiveness when injected with
GFP/LSSC cells from adult Ngn3-eGFP mice (PDL D7), since
their insulin release increased 2.6-fold when stimulated with 20
mmol/L glucose (Figure 5E).DISCUSSION
Our study demonstrates convincingly that the adult mouse pan-
creas contains islet cell progenitors and that expansion of the
b cell mass following injury induced by ligation of the pancreatic
duct depends at least partly on the activation of Ngn3 gene
expression and the ensuing differentiation of endogenous pro-
genitor cells in a cell-autonomous, fusion-independent manner.
Partial duct ligation induces a strong inflammatory response
and a loss of acinar cells. Both processes may be important in
signaling for increase of the b cell mass under these conditions
of injury, but it is unclear at this moment whether they play
a role in the normal physiology of a healthy pancreas where
the importance of self-duplication rather than stem cell differen-
tiation is well documented (Dor et al., 2004; Teta et al., 2007). Ac-
tivation of Ngn3 and doubling of the b cell mass could be
prevented up to 66% by Ngn3-specific RNA interference, sug-
gesting a considerable contribution of progenitor cells to the ob-
served b cell hyperplasia. In nonligated pancreas 67% of the
cells were transduced compared to only 18% in ligated pan-
creas. This difference is due to the disappearance of acinar cells,
the most abundant cell type of the infected pancreas and to
a massive recruitment of uninfected immune response cells to
the pancreas affected by inflammation following PDL. The effi-
cient Ngn3 knockdown can be explained by (1) the infection of
67% of pancreas cells before PDL is carried out, (2) the specific
location of an important fraction of Ngn3-expressing cells, tar-
gets of the interfering RNA, among or in contact with duct cells
that line the site of injection and therefore are exposed directly
to the virus, and (3) a near 100% knockdown of Ngn3 expression
by Le-sh1Ngn3 (Baeyens et al., 2006). The remaining increase in
b cell mass in spite of Ngn3 knockdown likely is due to cycling of
(1) pre-existing b cells and/or (2) progenitor cells that were unin-
fected or that had differentiated beyond the Ngn3+ stage before
being infected.Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc. 203
Figure 5. Ngn3+ Cells from Adult Pancreas Differentiate In Vitro into Functional b Cells
(A) The following is a schematic overview of the experiment: GFP/LSSC cells were isolated by flow cytometry from adult (PDL D7) or embryonic (E13.5) pancreas.
Embryonic pancreas was explanted from homozygous Ngn3 null mutant mice or their WT littermates at E12.5 (D-1). One day later (D0), 500 GFP/LSSC cells were
microinjected into the embryonic pancreas and kept in culture for 1 or 7 days.
(B) Following 1 day in culture, WT embryonic explants immunostained positive for insulin and glucagon but Ngn3/ embryonic explants did not, even when in-
jected with GFP/LSSC cells from adult PDL. After 1 week of culture, WT explants expressed insulin and glucagon, somatostatin, and pancreatic polypeptide but
Ngn3/ explants did not. However, when engrafted with GFP/LSSC cells from E13.5 or adult PDL pancreas, the four islet hormones were detected in Ngn3/
explants. Magnification bar is 100 mm.
(C) RNA was extracted from the explants described in (B), cultured for 1 (white bar) or 7 (gray bar) days and transcript levels encoding Ngn3, insulin 1 and 2, and
glucagon were determined by quantitative RT-PCR (see Experimental Procedures). The negative control contained no cDNA.
(D) While cell-cycle activity was high in the explant cultured for 1 day, the engrafted GFP/LSSC cells from adult PDL pancreas were out of cycle. After their
differentiation to insulin+ cells, however, the injected cells reinitiated cell cycle. Explants were labeled with BrdU during the last 16 hr of culture.
(E) The glucose-responsive insulin release by embryonic pancreas from Ngn3/ mice engrafted with GFP/LSSC cells was determined at day 1 and day 7 of
culture, following incubation in 6 mmol/L (white bars) or 20 mmol/L (gray bars) glucose for 24 hr. Explants from embryonic pancreas of WT mice and of nonen-
grafted Ngn3/ mice were taken as positive and negative control, respectively. All results shown are representative of three independent experiments.
*: p < 0.001 insulin release at 6 mmol/L versus 20 mmol/L glucose.204 Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc.
While under normal physiological conditions the slow course
of b cell proliferation is sufficient to compensate for their low
turnover and expansion (Dor et al., 2004; Teta et al., 2007), our
data in injured tissue demonstrate a rapid course of hyperplasia
that depends on progenitor cell recruitment. This pathway may
not be active after 50%–70% partial pancreatectomy (PPx)
(Dor et al., 2004; Teta et al., 2007), a less robust injury model in
which Ngn3-expressing cells remain absent (Lee et al., 2006)
and the b cell mass indeed increases much slower than following
duct ligation (Bouwens and Rooman, 2005).
The Ngn3+ islet cell progenitors coexpress cytokeratins when
located among the cells that line the pancreatic ducts and were
activated by PDL as shown by expression of Pdx1. In PDL pan-
creas, the Ngn3+ cells near and within islets did not express any
of the islet cell hormones, nor did permanently labeled islet cells
express Ngn3. Finally, islets isolated from PDL pancreas con-
tained less Ngn3 mRNA than total PDL pancreas, excluding
dedifferentiation of pre-existing islet cells as the basis of the phe-
nomena we describe. The detection of b-gal in the progeny of
Ngn3+ cells that already expressed the hormones, some of
which were in islets, suggests a migration from duct to islet by
the progenitor cells. The ultrastructure of Ngn3+ cells from adult
pancreas revealed an immature phenotype, but when injected in
an embryonic microenvironment that supports islet progenitor
differentiation, the GFP/LSSC cells became functional endocrine
islet cells among which were b cells with glucose responsive in-
sulin release. We confirmed that the 6 kb promoter recapitulates
the endogenous Ngn3 expression by performing PDL on the
pancreas of Ngn3eYFP/+ knock-add-on mice (Mellitzer et al.,
2004) and showing that YFP/LSSC cells are similar to the GFP/
LSSC cells found in PDL pancreas fromNgn3-GFPmice. The en-
dogenous progenitor cell type we isolated from adult mouse
pancreas is different from the atypical ones isolated from neona-
tal (Suzuki et al., 2004) or adult (Seaberg et al., 2004) mouse pan-
creas that expressed Ngn3 but had a high proliferation capacity
and gave rise to pancreatic (Seaberg et al., 2004; Suzuki et al.,
2004) and neuronal (Seaberg et al., 2004) cell types in vitro.
None of these expanded colonies formed islet cells with signifi-
cant glucose responsive insulin release. Recently, the nonendo-
crine fraction of the human pancreas, containing undifferentiated
epithelial cells that expressed markers of pancreatic duct cells,
was used to generate new insulin-producing cells when grafted
together with cells of fetal pancreas under the kidney capsule of
mice (Hao et al., 2006). An important similarity with our study is
the requirement of an embryonic microenvironment able to pro-
duce essential growth and differentiation factors. Cytokeratin 19,
themarker used by Hao et al. (2006) is ambiguous, though, since
it is expressed in islet cells undergoing dedifferentiation (Gao
et al., 2005). Ngn3, however, is the only unambiguous marker
known for islet progenitors in the embryonic (Gu et al., 2002)
and in the adult pancreas (present study). Our data provide the
first direct evidence for the existence of endogenous endocrine
islet cell progenitors in adult mouse pancreas. This cell popula-
tion is similar to the one that gives rise to the islets during embry-
onic development and represents an obvious target for thera-
peutic regeneration of b cells in diabetes. Indeed, our findings
reveal the significance of investigating the feasibility of (1) isolat-
ing facultative b cell progenitors and newly formed b cells fromhuman pancreas in order to expand and differentiate them
in vitro and transplant them in diabetic patients and (2) compos-
ing a mix of factors able to activate b cell progenitors to expand
and differentiate in situ in patients with an absolute or relative
deficiency in insulin.
EXPERIMENTAL PROCEDURES
Mouse Manipulations
All mice experiments were performed in accordancewith our institutional ‘‘Eth-
ical Committee for Animal Experiments’’ and national guidelines and regula-
tions. The pancreatic duct of 8 weeks old mice (Balb/C, C57BL/6 x CD1
Ngn3-nLacZ, Ngn3-eGFP, Ngn3eYFP/+ [Mellitzer et al., 2004], Ngn3-eGFP/
ROSA26-lacZ, Ngn3-eGFP/GCG-Cre/R26R, INS-Cre/R26R) was ligated as
described in rats (Wang et al., 1995) with some minor modifications. GCG-
Cre and INS-Crewere kindly provided by Pedro Herrera (University of Geneva),
and ROSA26-lacZ and R26R were from Philippe Soriano (Fred Hutchinson
Cancer Research Center). Following clamping of the distal bile duct, 60 ml
containing 2 3 107 TU of recombinant lentiviruses that express short hairpin
RNA molecules directed against Ngn3 (Le-sh1Ngn3 50-GTGCTCAGTTC-
CAATTCCA-30 and Le-sh2Ngn3 50-GACCCTGCGCTTCGCCCAC-30) or a ran-
dom control shRNA (Le-scr 50-GAGCATGCGAGCCATGCAC-30 ) (Baeyens
et al., 2006) were slowly injected in the pancreatic duct (Taniguchi et al.,
2003) or in explant of embryonic pancreas. We minimized possible off-target
effects by careful selection of the RNAi sequences using the siDESIGN Center
(http://www.dharmacon.com) (Reynolds et al., 2004). Candidate target shRNA
sequences were blasted against mouse transcript and genomic databases.
Their sequence similarity with genes other than Ngn3 (100% identity) was
‘‘not significant.’’ The highest similarity (74%–79% identity) was between
synuclein alpha and Sh1 and between Ngn2 or gastric inhibitory polypeptide
receptor and Sh2. From E12.5 or E13.5 embryos of WT or Ngn3/ mice,
the dorsal lobes of pancreas were isolated as described (Duvillie et al.,
2003; Miralles et al., 1998), cultured in RPMI1640 + 10% fetal calf serum
(Hyclone), and microinjected (Eppendorf TransferMan NK) with 500 GFP/
LSSC cells that were collected in a micropipette with 20 mm diameter.
Isolation and Labeling of Ngn3-eGFP Cells
GFP/LSSC cells were obtained from embryonic (E13.5) and adult (PDL D7)
pancreas of Ngn3-eGFP mice following dissociation to single cells (collage-
nase, 0.3 mg/ml and trypsin, 10 mg/ml, Sigma), filtration (30 mm), incubation
with PI (2mg/ml, Sigma), and TSQ (2 mg/ml, Molecular Probes) for 15 min and
sorting on a FACSAria (Becton Dickinson). GFP/LSSC cells were labeled by
incubation for 10min in presence of 5 mMCellTracker Orange CMTMR (Invitro-
gen, Molecular Probes).
RNA and Protein Analysis
Total RNA was isolated from tissue (RNeasy, QIAGEN) or cells (Picopure,
Arcturus). Only RNA with RNA Integrity Number R 7 (2100 BioAnalyzer,
Agilent) was further analyzed. cDNA synthesis and RT-PCR were done as
described (Mellitzer et al., 2006) using specific primers (Table S1). Quantitative
PCR was performed using mouse-specific primers and probes recognizing
insulin 1 (Mm01259683), insulin 2 (Mm00731595), glucagon (Mm00801712),
CD45 (Mm00448463_m1), F4/80 (Mm00802530_m1), and cyclophilin A
(Mm02342429) with TaqMan Universal PCR master mix on an ABI Prism
7700 Sequence Detector, and data were analyzed using the Sequence
Detection Systems Software, Version 1.9.1 (all Applied Biosystems). The
following sequences were used for analysis of Ngn3: 50-GTCGGGAGAACTAG
GATGGC-30 go (forward primer)p, 50-GGAGCAGTCCCTAGGTATG-30 (reverse
primer), and 50-CCGGAGCCTCGGACCACGAA-30 go(probe). The abundance of
Ngn3, insulin 1, insulin 2, glucagon, CD45, and F4/80 transcripts was normal-
ized versus the abundance of the transcript encoding the housekeeping pro-
tein cyclophilin A.
Samples for immunohistochemistry (IHC) were fixed in 4% formaldehyde
(FA) for 4 hr respectively at RT following embedding in paraffin or at 4C fol-
lowed by overnight in 20% sucrose and freezing. Samples for immunocyto-
chemistry (ICC) were fixed in 4% FA for 10 min. Paraffin sections (4–5 mm)Cell 132, 197–207, January 25, 2008 ª2008 Elsevier Inc. 205
were incubated with antisera specific for insulin (1/5000, guinea pig), glucagon
(1/3000, rabbit) and somatostatin (1/5000, rabbit) (generated at the Diabetes
Research Center, Brussels), pancreatic polypeptide (1/5000, rabbit, gift from
Lilly), synaptophysin (1/50, rabbit, Zymed), pan-keratin (1/1000, rabbit, Dako
Cytomation), amylase (1/500, rabbit, Sigma), PHH3 (1/400, rabbit, Upstate
Biotechnology), BrdU (1/10, mouse, Cappel), GFP (1/100, rabbit or goat,
Abcam), activated caspase 3 (1/200, rabbit, Cell Signaling), CD45 (1/50, rat,
BD-PharMingen), F4/80 (1/10, rat, Serotec), Ngn3 (1/2000, mouse, Ole
Madsen, Hagedorn Research Institute, Gentofte) (Zahn et al., 2004), and
Pdx1 (1/1000, rabbit), mouse-specific C peptide (1/6000, rabbit), and rat-
specific C peptide (1/6000, rabbit) (Beta Cell Biology Consortium, Antibody
Core). The primary rat-specific anti-C peptide was labeled using a fluoro-
phore-labeled Fab fragment directed against its Fc portion (Zenon, Molecular
Probes). Antigen retrieval was required for recognition of synaptophysin,
PHH3 and Ngn3 (microwave), BrdU, and pankeratin (proteinase K). Secondary
antibodies for detection of guinea pig, rabbit, goat, or mouse antibodies were
labeled by fluorescence (Cy3, Cy2, Cy5, or AMCA) (Jackson ImmunoResearch
Labs) or by ABC/DAB (DakoCytomation/Becton Dickinson). Signals of Ngn3
were amplified using the TSA-Cy3 System (Perkin Elmer Life). Nuclei were
labeled by Hoechst 33342 (4 mg/ml, Sigma) or Sytox green (5 mM, Invitrogen).
Images were viewed using normal (Zeiss Axioplan 2) or confocal scanning
(Leica DMIRE) microscopy and morphometrically analyzed using NIH ImageJ
(versus1.3.1). For electron microscopy samples were prepared as in Here-
mans et al. (2002).
Quantitative analysis of the b cell mass (calculated on the basis of at least 9
sections, 150 mm apart from each other, per pancreas tail or head) and the
number of BrdU+ insulin+ cells was done as described by Bogdani et al.
(2003) (Figure S9).
Insulin content of adult and embryonic pancreas andmedium insulin were de-
terminedby radioimmunoassayusingmouse insulinRIAkit (LincoResearch Inc.).
Glucose response of adult and embryonic GFP/LSSC cells, cultured in
Ngn3/ explants for 1 or 7 day(s), was assayed for insulin release in the
medium following incubation with 6 or 20 mmol/L glucose during the last 24
hr. Positive and negative controls were sham-injected embryonic pancreas
explants from WT and Ngn3/ mice, respectively.
Data Analysis
All values are depicted as mean ± standard error of the mean (SEM) from at
least three independent experiments and considered significant if p < 0.05.
All data were statistically analyzed by multivariate comparison (two-way
ANOVA) with Bonferroni correction or one-way ANOVA with Newman-Keuls
correction.
Supplemental Data
Supplemental Data include seven figures and one table and can be found with
this article online at http://www.cell.com/cgi/content/full/132/2/197/DC1/.
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